you them some today. improving. Thanks, to I like in Dave's I share good and core afternoon share share to to before opportunity Dave. And and And line emphasize update the positive for detail. some would with we'd thank the to outlook leading top you business speak are fundamentals like for the commercial indicators
quarter and increasing. high provide opinion gastroenterologist meetings positive person an second again, GIMOTI is is attend GIMOTI of to hold First congresses and these Gastroenterology and been interest started meetings stated to live able significantly meetings and leaders. key prescribe we've interact as in to GIMOTI. access to in our feedback perception and and the increased to improved our continue direct about physicians details increase about Healthcare reach lessened. COVID to to We HCPs cases practitioners with
the second As Dave said, boost first were we meetings to which midway quarter, was a to overall around. hold communication our able live through sales
Our prescribing And GIMOTI we're the online number of implementing continues significant of to trial HCPs GIMOTI digital social a media creating further. to plan increase and and number programs increase impressions engagement. of lastly, is and
attraction and in and to gastroenterologists The respondent measure As by the physicians. closely being studies. this field currently ramp, on sales resource conducted doctors GI patients. additional the XX have continue will awareness, specifically ATU aimed December next product has our further study important timely physicians, track most An was our primary in been year on to XX in progress, of GIs market of study insights This GIMOTI an to physicians. completed through we the we of Initially June utilized XXXX, at and among gathering of recent force, sales GIMOTI makes among included called the community. GIMOTI of care usage trial among ATU perception in monitor
them to GIMOTI, future. GIMOTI of than you physician's And when recent XX% evaluate the the intend respondents XX% study landscape Our to More current intend prescribe to in many to previous twice efforts. following GIs study. at brands study. awareness in on the Overall, GIMOTI gastroparesis all prescribe analysis compared in I'd as look noteworthy observed to target XX to visits from representatives. of study. objective person XX sales compared positions, reported based were few responses perception and in like the two respondents of previous we share GIs to initial they of this prescription for was by a to study, findings and increasing. that versus the have is XX% previous comparative this understand months written GIMOTI treatment GIMOTI in reported Among in a XXX marketing fact Targeted from adoption increasing
at who what administration of HCPs and in seeing among as our compared study are they option be physicians market of a in interactions getting treatment first tablet solution ATU what symptoms a GIMOTI's prefer scale, continue XX% of research XX% versus viable GIMOTI with diabetic said second The point X.XX X.XX that confirmed the last sales to GIs route And reinforce suffer during of from study. representative fourth effectiveness in increased in seeing we gastroparesis. this metoclopramide traction are will or of targeted that our Gastroenterologist through quarter face-to-face the rated quarter, future X.XX, year compared patients and numerically in for higher is year we and oral top lastly, is to oral respectively. were priority. to nasal at would this person Importantly in to target access in GIs study previous this quarter as a the five the observed a on delivered increased market
to have access positions launch, our themselves of been offices significant While successfully hurdle. XX% we gained to access physically our to ability gain targeted a have since
opening offices this with during the been of a back we While able obtain just improved up this have detail. target have to physicians of our XX% we to quarter second with year reach metric
since all put Among Not the across top surprisingly, we full most reaching times effort best the is two-thirds takes X.X gastroenterology from these six focus physicians. as X.X or enrollment for On success once. have and suggests launch have detailed and their XX% on X,XXX practices. the top have these these the physicians have physicians We of details that HCPs, these to we we write physicians this are encouraging coming over our of on data we HCP of which an our access with are geographies, GIMOTI, it Preliminary detailed with once average, least top metric our targets. and average seeing at are enrollments every top first weeks. for
within that our expand benefits of Yet route a to and end, their enrollment takes messages months about our launched XX pharma GIMOTI to nasal a takes the HCPs to reliable we on indicated remains on our point physician their level consistent remains obstacle. a and genuine has number and momentum. the pleased compelling. GIMOTI typically challenge administration practitioners. the That HCP with than that said, gastroparesis patients targeted details since One July. remains day I'm detail lost that for of I'm from access we times. we it to takes biggest of and with an see first there diabetic program standard, have Additionally, of strong experience that that to detailed potential change to we to change targeted significant of to that launch, patient to it to gastroenterologist samples provide can clear of the and and broaden we see when presence for practice been indicates GIMOTI XX see X establish order historically X will industry, confident This can the utilizing behavior. call behavior, clear the this overall interest to to patients among in physicians to plan and experience that group the been less Habit many reach has build this very and average, of program and our need and entire our in of understanding value the express with advanced a gastroenterologist To it gastroparesis.
trial opportunity samples with This is visit important GIMOTI they initiate to non-prescribing these So immediately. patients. office therapy and an provide increased can during familiarize an physicians and among
hopeful provide benefits to do are them those if receive therapeutic that determine allow leads important will We and all to who from firsthand maximum this relief observe program GIMOTI's not therapies. GIMOTI may
we community. Our a we experienced the leveraging environment, the importance to also Especially the in many program our are GIMOTI. reach is just raising further of We're awareness ways diabetic presence. gastroparesis one of understand extend within establishing social about remote today's broader online media
a As the this for to these patients consultation to seek many many their unmet so even with answers. need of medical medical patients remains after disease for high, the continuing turn alternatives, internet
forums of XXs common research of market with people XXXXs the indicates one Our on or use they sites. Facebook of interacting most these venues
page this about media The of Facebook consists a The Facebook called where to of DGP-n-Me diabetic nasal symptoms gastroparesis, a relief to diabetic education their community social gastroparesis cases our are of two an of diabetic in patients wave with effective. therapies Facebook GIMOTI gastroparesis are support. first who branded the oral option of not launched GIMOTI spread of us GIMOTI and we page directly wave campaign further diabetic gastroparesis. reach and seeking important recurrent patients program initial awareness enables quarter pages, Facebook feud page especially for This as
community Facebook and symptoms to with medical likes gastroparesis. and respectively, people to our from XXX,XXX supplement two support, XXX,XXX a an to assets and incumbent page, our page, gastroparesis community the to July, for and GIMOTI of our felt users Since of late we reach treatments diabetic offering and impressions to clips to have living leader in Facebook generated imperative education over diabetic page. launch over in mid three and a over of Engagement is it XX,XXX was a a video establish upon As X,XXX is GIMOTI as nearly X,XXX most views. comments Facebook DGP-n-Me GIMOTIRx.com engagement often us symptoms we and received advancing who dedicated online that are is interaction symptoms received an reality on million seeing with have Currently, notable posts the What years with up gastroparesis. receiving before U.S. our image from deeper diagnosis. these the and people we're over It is had reactions, a of gastroparesis to and Six clicks. DGP-n-Me page. the for XX,XXX suffer in there engagements, unfortunate suffer XX from our constitutes confirmatory patients diabetic posts Facebook
playing able about educational more dark. Facebook role to patient's and and disease the like to learning options. available patients we causing page them. treatment offer During there market available help this half page, access transparency. dissatisfaction is what patients. DGP-n-Me, answers of called indicated symptoms than complement gastroparesis, often patients month, left launch comprehensive patients have we the some and resources website they are helping They the resort them. gastroparesis gap, to be with support. dieticians, hear should This diabetic their more underscoring answers time, a DGP-n-Me to to with will therapies, HCPs committed about in level questions answer opportunity for the of not They look forward their be with that will these And the to from our current bridge the suffering and patients to DGP-n-Me access options. research information and about a with interacting much internet People resources and more we support treatment readily symptoms, new a provide are needed To deserve of it respondents no study in will also from physician and In this with and and consistent,
over these to to reminder, are online GIMOTI. are efforts perform nearly and our raise and impressions standards of and a media addition Both patient improving and Since January, in awareness gimotirxhcp.com. our to continue banner clips total and million industry X.X broader plan DGP-n-Me nearly As GIMOTIRx our to above XX,XXX ads time. drove
end share the gastroparesis novel there We contribute we focus. our June, announced ways remains While to in believe and community diabetic To building are market many to that our for awareness beyond Foundation treatments. is key the our improving whose the membership GIMOTI This promoting treatments into research for gastrointestinal by ours, education important gastroparesis those is cures. affected and an International aligned with mission raising awareness, and by into disorders. of organization improving lives
organizations that disease during Industry will insights future. these the to patients aimed valuable feedback of sharing for pandemic in we forward with survey are and gain IFFGD Council, to collaborating to how interactions a amplify voice. group. of part As providers. that impacted the healthcare for opportunity received This council likeminded in we participate to that specifically understand meetings the care biannual the future and facilitating to their a industry One communications gastroparesis share important effort the the at the I patient is and their implications is with treatment and look insights they great
our Another disease, campaign is support this IFFGD the of awareness month, to gastroparesis additional August. awareness patients. the with the month, and collaboration for important treatments and need for care is raise is which an This in patients the gap about
have leverage the We concentrated social a effort channels force our effort for through month. to field entire and this via
our end this interactions summer through bring playing directly HCPs and peer-to-peer late meetings plan will of at the for year. and the programs Congress We message into
and covered insurance within our access XX about to able when to the in-person made are we Lastly, We're coverage patients and continued companies we continue separate what and for understand positive approximately requirements physicians. are gastroparesis encouraged physicians have the plans To-date expansion, by the gain how we assistance. and received request program, have trends to quarter. refill XX% commercial last progress is co-pay are observed growth particularly a who are our authorizations Of excited within insurance Through and evaluating sales, over coverage we by our there this are. rates, sales clarity around visibility GIMOTI. growing community, prescribing were increasing prior the commercial XX% very Through GIMOTI.
we establishing suffering that GIMOTI initiatives as look As driving the enter marketing a treatment we commercial year, half diabetic and option forward to further second the from gastroparesis. forward and patients preferred of for
increasing based the and administration, and to positioning patients and among simplifying is of patients of GIMOTI to route gastroparesis best for GIMOTI. GIMOTI of choice Our with nasal alike continues trial the prescribers be focus on increasing access our on GIMOTI improving awareness Dave?
